Bolt Biotherapeutics, Inc. Quarterly Depreciation in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Bolt Biotherapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q2 2024.
  • Bolt Biotherapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $400K, unchanged year-over-year.
  • Bolt Biotherapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $1.9M, a 5.56% increase year-over-year.
  • Bolt Biotherapeutics, Inc. annual Depreciation for 2023 was $1.9M, a 11.8% increase from 2022.
  • Bolt Biotherapeutics, Inc. annual Depreciation for 2022 was $1.7M, a 41.7% increase from 2021.
  • Bolt Biotherapeutics, Inc. annual Depreciation for 2021 was $1.2M, a 100% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.9M $400K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.9M $500K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.9M $500K $0 0% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $1.9M $500K +$100K +25% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.8M $400K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $1.8M $500K +$100K +25% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $1.7M $500K +$100K +25% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $1.6M $400K +$100K +33.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.5M $400K +$200K +100% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $1.3M $400K +$100K +33.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $1.2M $400K +$200K +100% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $1M $300K +$100K +50% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $900K $200K +$100K +100% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $800K $300K +$200K +200% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $600K $200K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $200K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $100K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $100K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.